Regulation of lymphocyte development and function by RNA-binding proteins

Current Opinion in Immunology

Volumn 24, Issue 2, 2012, Pages 160-165

  Turner, Martin ^a   Hodson, Daniel ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; REGULATOR PROTEIN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; UNTRANSLATED RNA;

CELL FATE; CELL MATURATION; DEVELOPMENTAL STAGE; GENE EXPRESSION REGULATION; HUMAN; LYMPHOCYTE FUNCTION; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; RNA SEQUENCE; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; LYMPHOCYTES; LYMPHOPOIESIS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84859126410     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.01.011     Document Type: Review

References (49)

1. Cedar H., Bergman Y. Epigenetics of haematopoietic cell development. Nat Rev Immunol 2011, 11:478-488.
2. Lam L.T., Pickeral O.K., Peng A.C., Rosenwald A., Hurt E.M., Giltnane J.M., Averett L.M., Zhao H., Davis R.E., Sathyamoorthy M., et al. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol 2001, 2. RESEARCH0041.
3. Cheadle C., Fan J., Cho-Chung Y.S., Werner T., Ray J., Do L., Gorospe M., Becker K.G. Control of gene expression during T cell activation: alternate regulation of mRNA transcription and mRNA stability. BMC Genomics 2005, 6:75.
4. Dolken L., Ruzsics Z., Radle B., Friedel C.C., Zimmer R., Mages J., Hoffmann R., Dickinson P., Forster T., Ghazal P., et al. High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA 2008, 14:1959-1972.
5. Hao S., Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 2009, 10:281-288.
6. Barenco M., Brewer D., Papouli E., Tomescu D., Callard R., Stark J., Hubank M. Dissection of a complex transcriptional response using genome-wide transcriptional modelling. Mol Syst Biol 2009, 5:327.
7. Elkon R., Zlotorynski E., Zeller K.I., Agami R. Major role for mRNA stability in shaping the kinetics of gene induction. BMC Genomics 2010, 11:259.
8. Rabani M., Levin J.Z., Fan L., Adiconis X., Raychowdhury R., Garber M., Gnirke A., Nusbaum C., Hacohen N., Friedman N., et al. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat Biotechnol 2011, 29:436-442.
9. Schwanhausser B., Busse D., Li N., Dittmar G., Schuchhardt J., Wolf J., Chen W., Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342.
10. Mazumder B., Seshadri V., Fox P.L. Translational control by the 3'-UTR: the ends specify the means. Trends Biochem Sci 2003, 28:91-98.
11. Frith M.C., Pheasant M., Mattick J.S. The amazing complexity of the human transcriptome. Eur J Hum Genet 2005, 13:894-897.
12. Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 2010, 10:24-35.
13. Mazumder B., Li X., Barik S. Translation control: a multifaceted regulator of inflammatory response. J Immunol 2010, 184:3311-3319.
14. Ghosh M., Aguila H.L., Michaud J., Ai Y., Wu M.T., Hemmes A., Ristimaki A., Guo C., Furneaux H., Hla T. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J Clin Invest 2009, 119:3530-3543.
15. Papadaki O., Milatos S., Grammenoudi S., Mukherjee N., Keene J.D., Kontoyiannis D.L. Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR. J Immunol 2009, 182:6779-6788.
16. Mukherjee N., Lager P.J., Friedersdorf M.B., Thompson M.A., Keene J.D. Coordinated posttranscriptional mRNA population dynamics during T-cell activation. Mol Syst Biol 2009, 5:288.
17. Sadri N., Lu J.Y., Badura M.L., Schneider R.J. AUF1 is involved in splenic follicular B cell maintenance. BMC Immunol 2010, 11:1.
18. Hodson D.J., Janas M.L., Galloway A., Bell S.E., Andrews S., Li C.M., Pannell R., Siebel C.W., MacDonald H.R., De Keersmaecker K., et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol 2010, 11:717-724.
19. Bellavia D., Mecarozzi M., Campese A.F., Grazioli P., Talora C., Frati L., Gulino A., Screpanti I. Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing. EMBO J 2007, 26:1670-1680.
20. Stadanlick J.E., Zhang Z., Lee S.Y., Hemann M., Biery M., Carleton M.O., Zambetti G.P., Anderson S.J., Oravecz T., Wiest D.L. Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors. J Immunol 2011, 187:664-675.
21. Anderson S.J., Lauritsen J.P., Hartman M.G., Foushee A.M., Lefebvre J.M., Shinton S.A., Gerhardt B., Hardy R.R., Oravecz T., Wiest D.L. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 2007, 26:759-772.
22. Ramgolam V.S., DeGregorio S.D., Rao G.K., Collinge M., Subaran S.S., Markovic-Plese S., Pardi R., Bender J.R. T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade. PLoS One 2010, 5:e14450.
23. Scheu S., Stetson D.B., Reinhardt R.L., Leber J.H., Mohrs M., Locksley R.M. Activation of the integrated stress response during T helper cell differentiation. Nat Immunol 2006, 7:644-651.
24. Villarino A.V., Katzman S.D., Gallo E., Miller O., Jiang S., McManus M.T., Abbas A.K. Posttranscriptional silencing of effector cytokine mRNA underlies the anergic phenotype of self-reactive T cells. Immunity 2011, 34:50-60.
25. Vinuesa C.G., Cook M.C., Angelucci C., Athanasopoulos V., Rui L., Hill K.M., Yu D., Domaschenz H., Whittle B., Lambe T., et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005, 435:452-458.
26. Yu D., Tan A.H., Hu X., Athanasopoulos V., Simpson N., Silva D.G., Hutloff A., Giles K.M., Leedman P.J., Lam K.P., et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007, 450:299-303.
27. Glasmacher E., Hoefig K.P., Vogel K.U., Rath N., Du L., Wolf C., Kremmer E., Wang X., Heissmeyer V. Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression. Nat Immunol 2010, 11:725-733.
28. Bertossi A., Aichinger M., Sansonetti P., Lech M., Neff F., Pal M., Wunderlich F.T., Anders H.J., Klein L., Schmidt-Supprian M. Loss of Roquin induces early death and immune deregulation but not autoimmunity. J Exp Med 2011, 208:1749-1756.
29. Vavassori S., Shi Y., Chen C.C., Ron Y., Covey L.R. In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells. Eur J Immunol 2009, 39:2224-2232.
30. Hamilton B.J., Genin A., Cron R.Q., Rigby W.F. Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression. Mol Cell Biol 2003, 23:510-525.
31. Porter J.F, Vavassori S., Covey L.R. A polypyrimidine tract-binding protein-dependent pathway of mRNA stability initiates with CpG activation of primary B cells. J Immunol 2008, 181:3336-3345.
32. Nowak U., Matthews A.J., Zheng S., Chaudhuri J. The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nat Immunol 2011, 12:160-166.
33. Basu U., Meng F.L., Keim C., Grinstein V., Pefanis E., Eccleston J., Zhang T., Myers D., Wasserman C.R., Wesemann D.R., et al. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 2011, 144:353-363.
34. Frasca D., Landin A.M., Alvarez J.P., Blackshear P.J., Riley R.L., Blomberg B.B. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol 2007, 179:918-927.
35. Baou M., Jewell A., Muthurania A., Wickremasinghe R.G., Yong K.L., Carr R., Marsh P., Murphy J.J. Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. Leukemia 2009, 23:986-989.
36. Graham J.R., Hendershott M.C., Terragni J., Cooper G.M. mRNA degradation plays a significant role in the program of gene expression regulated by phosphatidylinositol 3-kinase signaling. Mol Cell Biol 2010, 30:5295-5305.
37. Sandler H., Stoecklin G. Control of mRNA decay by phosphorylation of tristetraprolin. Biochem Soc Trans 2008, 36:491-496.
38. Maitra S., Chou C.F., Luber C.A., Lee K.Y., Mann M., Chen C.Y. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA 2008, 14:950-959.
39. Benjamin D., Schmidlin M., Min L., Gross B., Moroni C. BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites. Mol Cell Biol 2006, 26:9497-9507.
40. Schmidlin M., Lu M., Leuenberger S.A., Stoecklin G., Mallaun M., Gross B., Gherzi R., Hess D., Hemmings B.A., Moroni C. The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J 2004, 23:4760-4769.
41. Sun L., Stoecklin G., Van Way S., Hinkovska-Galcheva V., Guo R.F., Anderson P., Shanley T.P. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem 2007, 282:3766-3777.
42. Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., Xiao B., Worley P.F., Powell J.D. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 2011, 12:295-303.
43. Chapman M.A., Lawrence M.S., Keats J.J., Cibulskis K., Sougnez C., Schinzel A.C., Harview C.L., Brunet J.P., Ahmann G.J., Adli M., et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011, 471:467-472.
44. Iwanaga E., Nanri T., Mitsuya H., Asou N. Mutation in the RNA binding protein TIS11D/ZFP36L2 is associated with the pathogenesis of acute leukemia. Int J Oncol 2011, 38:25-31.
45. Wiestner A., Tehrani M., Chiorazzi M., Wright G., Gibellini F., Nakayama K., Liu H., Rosenwald A., Muller-Hermelink H.K., Ott G., et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood 2007, 109:4599-4606.
46. Sandberg R., Neilson J.R., Sarma A., Sharp P.A., Burge C.B. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320:1643-1647.
47. Mayr C., Bartel D.P. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
48. Konig J., Zarnack K., Rot G., Curk T., Kayikci M., Zupan B., Turner D.J., Luscombe N.M., Ule J. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol 2010, 17:909-915.
49. Ingolia N.T., Lareau L.F., Weissman J.S. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of Mammalian proteomes. Cell 2011, 147:789-802.